Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology

• Published in: Cytogenetic and genome research Vol. 160; no. 2; p. 57
• Main Authors: Xue, Shuya, Yan, Huanchen, Chen, Jingsi, Li, Nan, Wang, Jiayan, Liu, Yu, Zhang, Huimin, Li, Shaoying, Zhang, Wei, Chen, Dunjin, Chen, Min
• Format: Journal Article
• Language: English
• Published: Switzerland 01.04.2020
• Subjects: Adult; Chromosome Disorders - diagnostic imaging; Chromosome Disorders - genetics; Female; Genetic Counseling; Gestational Age; Humans; Maternal Age; Nuchal Translucency Measurement - methods; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Diagnosis - methods; Ultrasonography; Whole Exome Sequencing - methods; Young Adult; Nuchal translucency; Genetic counseling; Prenatal diagnosis; Microarray; Exome sequencing
• ISSN: 1424-859X
• DOI: 10.1159/000506095

This study aims to investigate the value of chromosomal microarray analysis (CMA) and whole exome sequencing (WES) in fetuses with increased nuchal translucency (defined as NT above the 95th centile for the crown-rump length). A total of 374 singleton pregnancies with gestational ages ranging from 11 to 13 + 6 weeks were investigated. Ultrasound displayed increased NT and no detectable structural malformations in these fetuses. Pregnancies were divided into 4 groups according to the NT values: 95th centile-3.4 mm (114 cases); 3.5-4.4 mm (150 cases); 4.5-5.4 mm (55 cases); and ≥5.5 mm (55 cases). The possible chromosomal anomalies were all analyzed by CMA first. Furthermore, 24 cases with increased NT but negative CMA results were investigated by WES, and the outcomes were followed up. Among all the 374 cases, causative genetic defects were detected in 100/374 (26.7%) of the cases along with 9 variants of unknown significance (VOUS) by CMA. CMA testing yielded 30 pathogenic variants (30/55), accounting for a detection rate of 54.5%, and 1 VOUS in the group of NT ≥5.5 mm, indicating the highest detection rate in the 4 groups. The 24 cases of the CMA negative sub-cohort with WES analysis further yielded 2 VOUS and 3 likely pathogenic variants, including 2 dominant de novo mutations in SOS1 and ECE1 and 1 recessive inherited compound heterozygous mutation in PIGN, which are associated with cardiac defects. All 3 cases opted for termination of pregnancy (TOP). In addition, 2 cases with increased NT were negative by both CMA and WES analysis, and fetal demise occurred. In conclusion, for the investigation of fetuses with increased NT exome sequencing is suggested to be considered in cases with negative CMA findings. However, appropriate genetic counseling should be given to optimizing its utilization in prenatal diagnosis.